SUBSCRIBE
SUBSCRIBE
News   Deals

Merck & Co., Inc. (JOBS) Inks Domestic Rights to Afluria from CSL Limited

September 29, 2009 | 
1 min read
Bookmark and Share

Bizjournals.com -- Merck & Co. Inc. entered into a deal Monday for the U.S. rights to Afluria, a seasonal influenza vaccine manufactured by CSL Ltd. of Australia.
Mergers & acquisitions
Merck & Co.
MORE ON THIS TOPIC
Pictured: Bristol Myers Squibb office in California
Cancer
BMS Bets $850M on Janux’s Tumor-Activated Drugs, Deepening Cancer Investments
January 22, 2026
 · 
2 min read
 · 
Tristan Manalac
Insights
From Sound Bites to Signals: Editors Parse Executive and Investor Chatter at JPM
January 22, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
Facade of Novo Nordisk's office in Fremont, California
Cell therapy
After Cell Therapy Retreat, Novo Offloads Technologies in Deepened Aspect Pact
January 21, 2026
 · 
2 min read
 · 
Tristan Manalac
Reaching an agreement. Businessmen shake hands and make a deal. vector
Collaboration
GSK Joins Growing PD-1 SubQ Push With Alteogen Alliance Worth up to $285M+
January 21, 2026
 · 
1 min read
 · 
Tristan Manalac